| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Globus Medical, Inc.$78.11
+1.47 (+1.92%)
C 58Pipeline Score MedTech · Commercial
Market Cap
11.51 B
EPS
4.35
P/E Ratio
19.75 $
Value Trade
126.14 M
SEC Financials
Q1 2026Dilution Risk
Revenue
759.85 M
R&D Expenses
36.51 M
Operating CF
202.36 M
Total Assets
5.44 B
Total Liabilities
707.24 M
Equity
4.73 B
D/E Ratio
12,345
10.24 %
Week
-10.22 %
1 Month
-6.48 %
3 Month
2.18 %
6 Month
18.22 %
5 Year
547.4 %
All Time
Cash Data
Cash Position
629.85 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 7, 2026
Overview
Volume
1.55 M
52 Week Range
51.79 - 101.40
% held by Insiders
17.15 %
% held by Institutions
82.43 %
Enterprise Value
10.99 B
Total Shares
135.80 M
Short %
5.59 %
Float Shares
132.54 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
C58
Pipeline Score $9.0B
Pipeline ValueValuation Signal
1
Drugs Scored2.6x
rNPV / MCap Top 85%
Mid Cap (rank 138 of 911)
Percentile RankGlobus Medical, Inc. carries a moderate pipeline score (58/100), with $10.6B risk-adjusted pipeline value, led by XL TDR, Lumbar fusion surgery in Degenerative Disc Disease (Phase 3).
Showing 1 of 1 assets
| Drug | Indication | Phase | NCT ID | PTRS | rNPV | Status | Enrollment | Velocity | Design | Completion | ML Signal | Last Change |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XL TDR, Lumbar fusion surgery Unknown | Degenerative Disc Disease | Phase 3 | NCT00927238 | 57% | $10.6B | COMPLETED | 246 | - | - | Jul 1, 2015 | - | Jul 30, 2015 |
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in GMED
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
GMED Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
GMEDGlobus Medical Reports First Quarter 2026 Results
Globus Medical, Inc. reported a strong financial performance for Q1 2026, with worldwide net sales reaching $759.9 million, a 27% increase year-over-year. The company achieved record earnings, with GAAP diluted EPS rising to $0.90, marking a 66.6% increase. The growth was driven by strong performance in core spine and the integration of Nevro. The company reaffirmed its full-year revenue guidance of $3.18 billion to $3.22 billion.
Read more →GMEDGlobus Medical Reports First Quarter 2026 Results AUDUBON, PA.
Globus Medical, Inc. announced its financial results for the first quarter of 2026, reporting a total revenue increase of 27% to $759.9 million compared to the same quarter in 2025. The company achieved a GAAP net income of $124.3 million, representing a significant 64.7% increase. Organic growth in the core spine market was highlighted, with overall procedural volume strength contributing to the positive results. The firm has reaffirmed its full-year 2026 revenue guidance while raising its forecast for non-GAAP fully diluted EPS.
Read more →GMEDGlobus Medical Schedules First Quarter Earnings Release and Conference Call
Globus Medical, Inc. will release its financial results for Q1 2026 on May 7, 2026. Following the announcement, a teleconference will be held to discuss the results with investors. Participants can join via webcast or telephone, with an audio archive available afterward. The company emphasizes its dedication to addressing clinical needs in musculoskeletal technology.
Read more →GMEDGlobus Medical Announces Board Departure
Globus Medical, Inc. announced the immediate departure of John A. DeFord, PhD, from its Board of Directors. He will not seek re-election at the upcoming Annual Meeting of Stockholders. The company expressed gratitude for his contributions, particularly during the merger with NuVasive, and wished him success in future endeavors.
Read more →GMEDGlobus Medical Announces Board Departure AUDUBON, Pa.
Globus Medical, Inc. announced the departure of Board Director John A. DeFord, who will not seek re-election at the upcoming Annual Meeting of Stockholders. The Chairman of the Board expressed gratitude for DeFord's contributions, particularly during the merger with NuVasive. DeFord highlighted his privilege in serving alongside a dedicated team while witnessing the company's growth in musculoskeletal technology.
Read more →GMEDGlobus Medical, Inc. Investigated by the Portnoy Law Firm
The Portnoy Law Firm has initiated an investigation into Globus Medical, Inc. amidst allegations of possible securities fraud affecting investors. The investigation follows a significant stock price decline after the FDA issued a warning regarding concerns over the company’s Class II Excelsius GPS surgical robot. Investors are being encouraged to seek legal recourse through the firm, which has a history of recovering substantial amounts for clients. This situation raises concerns regarding the company's compliance with quality regulatory standards.
Read more →GMEDGlobus Medical Reports Fourth Quarter and Full Year 2025 Results
Globus Medical reported strong financial results for Q4 and full year 2025, with significant growth in sales and earnings. The company achieved a 25.7% increase in worldwide net sales for Q4 and an 18.4% increase for the full year. The integration of Nevro contributed positively to their performance, and they provided optimistic guidance for 2026.
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED) will release its financial results for the fourth quarter and full year ended December 31, 2025 on February 24, 2026, post market close. Following the announcement, a teleconference will occur at 4:30 p.m. Eastern Time to discuss performance with investors. The company emphasizes its role as a leading provider of musculoskeletal solutions and mentions the availability of the release and conference call via its website.
Read more →GMEDGlobus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results AUDUBON, PA
Globus Medical, Inc. reported preliminary unaudited sales results showing a substantial increase in sales for the fourth quarter and full year of 2025. Fourth quarter sales are expected to reach approximately $823.2 million, marking a 25.2% growth compared to the same period in 2024, while full year sales are projected at around $2.936 billion, reflecting a 16.5% increase. The company expressed confidence in sustaining this momentum into 2026, amidst integration efforts of recent acquisitions. However, the results are preliminary and subject to revision pending final audits.
Read more →GMED▲ +35.9%on this news
Globus Medical Reports Third Quarter 2025 Results
Globus Medical, Inc. reported strong financial results for Q3 2025, with a 23% increase in revenue driven by growth in its US Spine business and the successful integration of the Nevro acquisition. The company achieved record non-GAAP free cash flow and significantly improved earnings per share. Looking ahead, Globus Medical has raised its revenue and earnings guidance for the full year.
Read more →GMEDxFEFF;  Globus Medical Reports Third Quarter 2025 Results  AUDUBON, PA, November 6 , 202 5 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial r
Globus Medical, Inc. reported its financial results for Q3 2025, showcasing a 23% revenue increase primarily due to growth in its US Spine business. The acquisition of Nevro has positively impacted revenue and is expected to contribute to future earnings. The company's non-GAAP earnings per share rose significantly, reaching $1.18, a 42.6% increase from the previous year. Looking forward, Globus Medical has raised its annual revenue guidance, signifying confidence in sustained growth and operational efficiency.
Read more →GMEDGlobus Medical Schedules Third Quarter Earnings Release and Conference Call
Globus Medical, Inc. will release its financial results for the third quarter of 2025 on November 6, after market close. A teleconference will follow at 4:30 p.m. ET to discuss the results with investors. Participants can join via webcast or telephone, with registration required for the latter. The audio archive will be available post-call.
Read more →GMEDGlobus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
Globus Medical has launched the ANTHEM™ Elbow Fracture System, a comprehensive plating portfolio aimed at treating a variety of elbow fractures. The system features anatomically contoured plates and polyaxial locking technology, enhancing surgical flexibility and precision. Surgeons have praised its design for improving fixation and minimizing disruption during procedures. This launch underscores Globus Medical's commitment to advancing trauma care.
Read more →GMEDGlobus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.
Globus Medical, Inc. announced a favorable jury verdict in its patent litigation against Life Spine, Inc., confirming that Life Spine's Prolift implants infringed on Globus's patents. The jury awarded Globus lost profits and reasonable royalties. This decision reinforces Globus's commitment to protecting its intellectual property and innovation in spinal surgery technologies.
Read more →GMEDxFEFF;  Globus Medical Reports Second Quarter 2025 Results  AUDUBON, PA, August 7 , 202 5 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial re
Globus Medical, Inc. (NYSE: GMED) reported robust financial results for the second quarter of 2025, marked by an 18.4% increase in worldwide net sales compared to the prior year. The U.S. Spine business experienced significant growth, achieving its highest sequential revenue growth since Q2 2022. The company reported a remarkable increase in GAAP net income by 538.7%, largely attributed to a bargain purchase gain and tax benefits. Globus Medical reaffirmed its full-year guidance, demonstrating confidence in sustained growth and operational efficiency moving forward.
Read more →GMEDGlobus Medical Reports Second Quarter 2025 Results
Globus Medical, Inc. (NYSE: GMED) reported its financial results for Q2 2025, highlighting an 18.4% increase in worldwide net sales to $745.3 million. The company experienced a remarkable 538.7% growth in GAAP net income, largely due to a bargain purchase gain. The U.S. Spine division was particularly strong, achieving its highest sequential revenue growth since Q2 2022. Looking ahead, Globus reaffirmed its annual guidance with expected revenue between $2.80 billion and $2.90 billion for the full year.
Read more →GMED▼ -7.9%on this news
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results
Globus Medical has announced leadership changes, appointing Keith Pfeil as President and CEO, while Daniel Scavilla resigns to pursue other opportunities. The company also reported preliminary second quarter sales results, projecting an 18.4% increase year-over-year. Pfeil aims to continue the company's growth trajectory, particularly in the US Spine sector.
Read more →GMED▼ -7.9%on this newsshared move
xFEFF;  Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results AUDUBON, PA
Globus Medical, Inc. announced significant leadership transitions with Keith Pfeil appointed as the new CEO, taking over from Dan Scavilla. The company reported preliminary sales figures for Q2 2025, estimating an 18.4% increase from Q2 2024, with a particular emphasis on growth in the US Spine business. Additionally, Kyle Kline has been promoted to CFO, marking a reshuffle in financial leadership. The company reaffirmed its revenue projections for 2025, showing optimism about future performance as it continues to focus on expanding its market presence in musculoskeletal technology.
Read more →GMEDGlobus Medical Schedules Second Quarter Earnings Release and Conference Call
Globus Medical, Inc. will announce its second quarter financial results for 2025 on August 7, following the market's close. A teleconference will be held at 4:30 p.m. Eastern Time, allowing investors to directly engage with the company's performance. Interested participants can access the call via a registration link provided. The company's commitment to innovation in the musculoskeletal sector remains a focal point, with updates available on their website.
Read more →GMEDGlobus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue
Globus Medical has launched the DuraPro™ oscillating system, enhancing its Power Portfolio with advanced navigation capabilities. This system aims to improve surgical workflows by safeguarding delicate tissues and providing accurate cutting instruments. The DuraPro™ integrates seamlessly with existing technologies, offering surgeons enhanced confidence during procedures. The company continues to address unmet clinical needs in the musculoskeletal market.
Read more →GMED▲ +5.9%on this news
Globus Medical Announces $500 Million Share Repurchase Program
Globus Medical, Inc. has announced a $500 million share repurchase program authorized by its Board of Directors. The company believes that the current share price does not reflect its intrinsic value, indicating confidence in its growth and profitability. The program will be executed based on market conditions and is part of a broader capital allocation strategy.
Read more →GMEDxFEFF;  Globus Medical Announce s $500 M illion Share Repurchase Program  AUDUBON, Pa. –
Globus Medical has announced a $500 million share repurchase program authorized by its Board of Directors to enhance shareholder value. The CFO highlighted a disconnect between the company's market valuation and intrinsic value, expressing confidence in long-term growth. The execution of the program will depend on various factors including market conditions, and it lacks a specific time frame. While the repurchase initiative reflects a strong financial position, associated risks remain regarding market integration and competition.
Read more →GMEDxFEFF;  Globus Medical Reports First Quarter 2025 Results  AUDUBON, PA, May 8 , 202 5 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial result
Globus Medical, Inc. reported first quarter 2025 results, revealing a slight decrease in worldwide net sales of 1.4% year-over-year, attributed to challenges in Enabling Technology unit sales and international orders. However, the company showed resilience through improvements in core US spine sales and a strong increase in GAAP net income and diluted EPS. Notably, Globus Medical returned to a debt-free status after paying off its merger-related debt, while record free cash flow was achieved. The firm remains optimistic about continued growth, despite some headwinds.
Read more →GMEDGlobus Medical Reports First Quarter 2025 Results
Globus Medical, Inc. announced its financial results for Q1 2025, revealing worldwide net sales of $598.1 million, a decrease of 1.4% from the previous year. Despite the decline in net sales, the company reported an increase in GAAP net income to $75.5 million and a rise in non-GAAP diluted EPS to $0.68. The results were impacted by factors such as fewer enabling technology unit sales and supply chain disruptions. However, there was a positive outlook with strong performance in the US spine business and the company reaffirmed its full-year revenue guidance for 2025.
Read more →GMEDGlobus Medical completes acquisition of Nevro Corp.
Globus Medical has completed the acquisition of Nevro Corp., a move that is expected to enhance its position in the musculoskeletal market and deliver innovative solutions for treating chronic pain. The acquisition opens a market opportunity valued at $2.5 billion, allowing Globus Medical to expand its product offerings and alter treatment standards in the neuromodulation space. CEO Dan Scavilla expressed enthusiasm about accelerating market penetration of Nevro’s high-frequency technology. The full implications of the acquisition will be discussed in their upcoming earnings conference.
Read more →GMEDGlobus Medical completes acquisition of Nevro Corp. AUDUBON, Pa.
Globus Medical has successfully completed its acquisition of Nevro Corp, a company focused on innovative solutions for chronic pain treatment. This acquisition is expected to enhance Globus Medical's presence in the musculoskeletal market, unlocking a significant $2 billion market opportunity. The CEO highlighted excitement about broadening treatment options for chronic pain through this integration. Future discussions on the acquisition's impact will be addressed in the upcoming first quarter earnings call.
Read more →GMEDGlobus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades
Globus Medical, Inc. has launched two new products aimed at improving anterior lumbar interbody fusion procedures: the COHERE™ ALIF Spacer and Modulus™ ALIF Blades. The COHERE ALIF Spacer is a pioneering Porous PEEK™ interbody spacer that promotes bone in-growth while maintaining high imaging quality. Additionally, the Modulus ALIF Blades enhance procedural efficiency by allowing fixation options that streamline surgery. This launch is part of Globus Medical's strategy to expand its portfolio and address complex spine surgery challenges.
Read more →GMEDGlobus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting
Globus Medical, Inc. will showcase its technological innovations, including the ExcelsiusFlex™ surgical robotic navigation system for Total Knee Arthroplasty, at the 2025 Annual Meeting of the American Academy of Orthopedic Surgeons in San Diego. The company aims to highlight its extensive product portfolio and connect with healthcare professionals during the event. The meeting will take place from March 10-14, 2025, where Globus will also host a reception and a booth tour for analysts and investors to review its latest offerings.
Read more →GMEDGlobus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference
Globus Medical, Inc. (NYSE: GMED) has announced its participation in the Canaccord Genuity 2025 Musculoskeletal Conference taking place in San Diego. The company is scheduled to present on March 10, 2025, at 4:30 pm PT. This event provides an opportunity for the company to highlight its advancements in musculoskeletal technology and engage with investors. The presentation will be accessible via a live and archived webcast on the company's investor relations website.
Read more →GMEDxFEFF;  Globus Medical Reports Fourth Quarter and Full Year 2024 Results  AUDUBON, PA
Globus Medical, Inc. reported impressive financial results for the fourth quarter and full year of 2024, showing robust growth in net sales and income, spurred by the recent merger with NuVasive. Fourth quarter net sales reached $657.3 million, marking a 6.6% increase from the previous year, with full year sales climbing 60.6% to $2,519.4 million. The company announced solid future guidance, expecting substantial revenues and earnings per share for 2025, particularly following their anticipated acquisition of Nevro, Inc. Overall, the results reflect successful integration strategies and ongoing innovation in musculoskeletal technology.
Read more →GMEDGlobus Medical Reports Fourth Quarter and Full Year 2024 Results
Globus Medical, Inc. (NYSE: GMED) reported robust financial results for the fourth quarter and the full year of 2024, with worldwide net sales increasing by 6.6% and 60.6%, respectively. The company's GAAP net income for the quarter was $26.5 million, reflecting a 76.3% increase from the previous year. Significant growth was attributed to the successful integration of their merger and an uptick in spine product sales. Looking ahead, Globus Medical has reaffirmed its revenue guidance for 2025, anticipating further growth driven by its acquisition of Nevro, Inc.
Read more →GMEDGlobus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients AUDUBON, Pa. and
Globus Medical has announced a definitive agreement to acquire Nevro Corp in an all-cash transaction worth $250 million, with each share priced at $5.85. This acquisition is intended to broaden Globus's treatment offerings in neuromodulation and related technologies, positioning the company for future growth. The transaction has been unanimously approved by both companies' boards and is expected to close by late Q2 2025, pending shareholder and regulatory approvals. Nevro expects to benefit from Globus's scale and resources to expand its reach in pain management solutions.
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
Globus Medical, Inc. has announced the schedule for its fourth quarter and full year 2024 earnings release, which will occur after the market close on February 20, 2025. Following the earnings announcement, the company will host a teleconference to discuss the financial results with investors. The company emphasizes its role in the musculoskeletal sector and plans to communicate its performance transparently through these events.
Read more →GMEDGlobus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
Globus Medical, Inc. reported preliminary sales results for Q4 and the full year of 2024, indicating significant growth. The company anticipates fourth quarter sales of approximately $657 million, reflecting a 6.6% increase compared to the previous year. For the full year, sales are projected at $2.52 billion, marking a 60.6% rise. The results are largely attributed to successful execution post-merger with NuVasive, strengthening their market position and product innovation. The company has provided an optimistic revenue guidance range for 2025 as they continue to advance in the musculoskeletal market.
Read more →GMEDxFEFF;  Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results  AUDUBON, PA, January 8 , 202 5 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions compan
Globus Medical, Inc. (NYSE: GMED) announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2024, reporting sales of approximately $657 million for Q4 and $2.52 billion for the full year, marking significant year-over-year growth. This growth is attributed to the successful merger with NuVasive, which has strengthened the company's offerings in the spine industry. Looking ahead, Globus Medical has set a revenue guidance range of $2.66 billion to $2.69 billion for 2025, indicating optimism for continued expansion and innovation in its product portfolio. The final Q4 financial results are expected to be disclosed on February 20, 2025.
Read more →GMEDGlobus Medical Launches ExcelsiusHub™ Navigation System
Globus Medical, Inc. has launched the ExcelsiusHub™ navigation system, designed to improve spine surgery by providing real-time visualization and reducing dependence on X-ray imaging. This system enhances surgical accuracy and safety, featuring patient array shift tracking and flexible registration options. Medical professionals have praised its efficiency and potential for lower radiation exposure, contributing to better patient care across different surgical scenarios.
Read more →GMEDGlobus Medical Reports Third Quarter 2024 Results
Globus Medical, Inc. reported strong financial results for the third quarter of 2024, with worldwide net sales reaching $625.7 million, a 63.1% increase year-over-year. GAAP net income for the quarter was $51.8 million, with non-GAAP diluted EPS rising to $0.83, reflecting a 45.2% increase from the previous year. The company has boosted its revenue guidance for the full year to between $2.49 and $2.50 billion. Executives highlighted ongoing sales growth and successful product launches as key factors in the positive performance.
Read more →GMEDxFEFF;  Globus Medical Reports Third Quarter 202 4 Results  AUDUBON, PA, November 5 , 2024: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial re
Globus Medical, Inc. reported strong financial performance for the third quarter of 2024, with a 63.1% increase in worldwide net sales year-over-year, reaching $625.7 million. The company's net income also rose significantly to $51.8 million, alongside a diluted earnings per share of $0.38 compared to $0.01 in the same quarter last year. The positive results are attributed to robust spine product sales and the integration of NuVasive. Globus has increased its revenue guidance for the full year 2024 to between $2.49 and $2.50 billion, signaling continued growth momentum heading into 2025.
Read more →GMEDGlobus Medical to Participate in Orthopedic Trauma Association Annual Meeting
Globus Medical, Inc. will participate in the 40th Annual Meeting of the Orthopedic Trauma Association in Montréal, Canada, from October 23-26. The company will showcase its orthopedic trauma product portfolio, including the innovative PRECICE™ Ankle Salvage System. Attendees can participate in a workshop on internal limb reconstruction led by notable faculty members. This marks the second year Globus presents its advanced limb lengthening technology at the meeting, emphasizing their commitment to improving surgical outcomes.
Read more →GMEDGlobus Medical Launches the Next Wave of Orthopedic Trauma Solutions
Globus Medical, Inc. has expanded its orthopedic trauma product portfolio with several new system extensions in 2024, including the TENSOR™ Suture Button System, which has received FDA clearance. Other newly launched products include ANTHEM™ II Distal Radius Volar Plates and AUTOBAHN™ Trochanteric Nail PRO Instruments, which have received positive feedback from U.S. surgeons. The company's orthopedic trauma business is experiencing rapid growth, enabling it to address a diverse range of patient needs with innovative solutions.
Read more →GMEDGlobus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims regarding alleged wrongdoings by Globus Medical, Inc. (NYSE: GMED). This follows the company receiving a warning letter from the FDA due to deficiencies found during a recent inspection. The letter cited issues with complaint procedures related to their ExcelsiusGPS robotic system, resulting in a significant drop in the company's stock price after public disclosure. Investors are encouraged to assist the investigation and seek compensation for any losses incurred.
Read more →GMEDGlobus Medical Launches ADIRA™ XLIF™ Plate System
Globus Medical has announced the commercial launch of the ADIRA™ XLIF™ Plate System, marking a significant advancement in their lateral interbody product line. This system enables compatibility with various interbody spacers and offers enhancements in procedural workflows for spine surgery. Featuring rigid coupling mechanisms, the ADIRA™ system aims to improve stability during surgical procedures. The launch highlights Globus Medical's ongoing commitment to innovation in the musculoskeletal segment.
Read more →GMEDGLOBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Globus Medical, Inc. on Behalf of Globus Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating Globus Medical, Inc. on behalf of stockholders following the company's disclosure of receiving a warning letter from the FDA. This letter outlines deficiencies concerning the company's response to past FDA inspections, particularly related to product complaint procedures linked to the ExcelsiusGPS robotic system. The warning has resulted in a significant drop in Globus' stock price, prompting concerns over potential legal repercussions and compliance issues. Investors are encouraged to reach out to the law firm if they have relevant information or have suffered losses.
Read more →GMEDGlobus Medical Reports Second Quarter 2024 Results
Globus Medical, Inc. reported substantial growth in its second quarter of 2024, with worldwide net sales reaching $629.7 million, an increase of 115.9% compared to the same quarter in 2023. While non-GAAP earnings showed improvement, GAAP net income faced a significant decrease of 45% due to costs associated with acquisitions and restructuring. The company raised its revenue guidance for the full year 2024, showcasing confidence in its operational enhancements and product innovations. The strong performance is attributed to successful integration of NuVasive and an increase in spine product sales.
Read more →GMEDxFEFF;  Globus Medical Reports Second Quarter 202 4 Results  AUDUBON, PA
Globus Medical, Inc. reported substantial financial growth for Q2 2024, with worldwide net sales reaching $629.7 million, a 115.9% increase from the previous year. The company attributes this growth to the integration of NuVasive and an increase in spine product sales. Despite a significant rise in sales, GAAP net income saw a decline of 45% due to amortization and restructuring costs. In response to their performance, Globus has raised its revenue guidance for the year to between $2.47 and $2.49 billion.
Read more →GMEDGlobus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
Globus Medical, Inc. has announced the receipt of 510(k) clearance from the FDA for its ExcelsiusFlex robotic navigation platform and the ACTIFY 3D Total Knee System. These innovations aim to enhance surgical precision, flexibility, and implant integration in total knee arthroplasty procedures. The company plans to ramp up production and prepare for commercial release shortly, following the regulatory approval. These advancements highlight Globus Medical's commitment to developing cutting-edge technologies in the orthopedic surgical market.
Read more →GMEDGlobus Medical Reports First Quarter 2024 Results
Globus Medical, Inc. (NYSE: GMED) reported a significant increase in net sales for the first quarter of 2024, totaling $606.7 million, a 119.3% rise compared to the same period last year. Though the company experienced a GAAP net loss of $7.1 million, it noted substantial gains in non-GAAP earnings and cash flow. The successful integration of NuVasive is driving sales and product engagement, which the company believes will enhance patient care. Globus updated its annual revenue guidance, reflecting further anticipated growth as it continues to streamline operations within the combined entity.
Read more →GMEDxFEFF;  Globus Medical Reports First Quarter 202 4 Results  AUDUBON, PA, May 7 , 202 4 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial resul
Globus Medical, Inc. reported its financial results for the first quarter of 2024, showing strong growth in net sales and improved operational efficiency following the NuVasive merger. The company's worldwide sales increased by 119.3% over the previous year, driven by higher demand for spine products and enabling technologies. While there was a GAAP net loss of $7.1 million due to restructuring costs, non-GAAP diluted EPS rose by 36.4%. The updated full-year revenue guidance reflects optimism for continued growth.
Read more →GMEDxFEFF;  Globus Medical Reports Fourth Quarter and Full Year 20 2 3 Results  AUDUBON, PA, February 2 0 , 202 4 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today annou
Globus Medical, Inc. reported strong financial results for the fourth quarter and full year 2023, highlighting a successful merger with NuVasive. The company achieved record worldwide sales, with increases in both domestic and international markets, driven by spine product and enabling technology growth. However, the merger has led to a significant decline in GAAP net income for the fourth quarter, impacted by acquisition-related costs. Looking ahead, Globus Medical anticipates continued growth with a revenue guidance range set for 2024.
Read more →GMEDGlobus Medical Reports Fourth Quarter and Full Year 2023 Results
Globus Medical, Inc. has reported strong financial results for the fourth quarter and full year 2023, with worldwide net sales reaching $616.5 million in Q4, a 124.6% increase. The significant growth is attributed to the merger with NuVasive and increased sales of spine products. However, the GAAP net income for Q4 showed a substantial decline of 70% compared to the previous year, impacting overall earnings per share. Looking ahead, the company expects continued growth with a projected revenue range for 2024 of $2.450 to $2.475 billion.
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
Globus Medical, Inc. (NYSE:GMED) is scheduled to release its financial results for the fourth quarter and full year ending December 31, 2023, on February 20, 2024. Following this announcement, the company will host a teleconference to discuss its performance with investors at 4:30 p.m. Eastern Time. The event will provide insights into the company’s financial health and business strategy moving forward while remaining accessible through a live webcast and an audio archive on their website.
Read more →GMEDGlobus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
Globus Medical, Inc. has promoted Keith Pfeil to the roles of Chief Operating Officer and Chief Financial Officer, reflecting the company's confidence in his leadership capabilities. Having served as CFO since 2019, Pfeil will now oversee daily operations and overall financial performance. His promotion comes as the company aims to enhance operational efficiency and navigate ongoing integrations from its merger with NuVasive. The fourth quarter and full year financial results for 2023 are set to be announced on February 20, 2024.
Read more →GMEDxFEFF;  Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer  Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth  AUDUBON, P
Globus Medical has promoted Keith Pfeil to Chief Operating Officer and Chief Financial Officer, expanding his responsibilities to encompass both operational and financial management. Pfeil, who has over 20 years of experience, will play a crucial role in achieving the company's strategic goals and enhancing operational efficiency. The announcement comes as Globus prepares to release its fourth quarter and full-year financial results on February 20, 2024. This leadership change aims to support the company's ongoing integration with NuVasive and foster growth.
Read more →GMEDxFEFF;  Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results  AUDUBON, PA
Globus Medical, Inc. reported preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2023, showcasing a remarkable increase in revenues. The company anticipates fourth quarter sales of approximately $615.5 million, representing a 124.2% increase compared to the previous year. Full year sales are projected at around $1.567 billion, up 53.2% from 2022. Following the merger with NuVasive, management indicated successful integration and strong sales retention, with an optimistic outlook for 2024 product launches and revenue growth.
Read more →GMEDGlobus Medical Reports Third Quarter 2023 Results
Globus Medical, Inc. reported its financial results for Q3 2023, highlighting a 51.0% increase in worldwide net sales to $383.6 million, including results from its recent merger with NuVasive, which was completed on September 1, 2023. While GAAP net income decreased significantly to $1.0 million, the company’s non-GAAP diluted EPS improved to $0.57. Additionally, the firm has revised its annual revenue guidance for 2023 upwards to $1.55 billion, showing optimism for future growth despite the short-term challenges post-merger.
Read more →GMEDxFEFF;  Globus Medical Reports Third Quarter 2023 Results  AUDUBON, PA, November 7 , 2023 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial re
Globus Medical, Inc. announced its financial results for Q3 2023, highlighting a completed merger with NuVasive, which is expected to enhance innovation in the spine industry. The company reported a significant 51.0% increase in worldwide net sales year-over-year. However, GAAP net income plummeted by 97.9%, primarily due to merger-related expenses. On a brighter note, the company raised its full-year revenue guidance to $1.55 billion, up from the previous estimate of $1.125 billion.
Read more →GMEDGlobus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
Globus Medical, Inc. (NYSE: GMED) has announced its ongoing partnership as a silver sponsor at EUROSPINE 2023, scheduled for October 4-6 in Frankfurt. The company emphasizes its dedication to innovating musculoskeletal solutions for spine care, with opportunities for surgeons to engage with advanced technologies at their exhibition stand. Additionally, Globus Medical will participate in several conferences later in 2023, reinforcing its active role in the medical community for spine care advancements.
Read more →GMEDGlobus Medical Completes Merger with NuVasive
Globus Medical has finalized its merger with NuVasive, creating a prominent musculoskeletal solutions company. This combination enhances their capabilities in spine and orthopedic care, aiming to improve patient outcomes. The merged entity showcases a comprehensive portfolio and increased operational efficiency, which is expected to create significant value for stakeholders. Leaders from both companies express optimism about the future and the potential for growth in addressing patient needs globally.
Read more →GMEDGlobus Medical Completes Merger with NuVasive Creates leading global musculoskeletal company Robust portfolio well-positioned for long-term growth and continued innovation AUDUBON, Pa.
Globus Medical has completed its merger with NuVasive, creating a prominent global player in the musculoskeletal solutions market. This combination aims to enhance their product offerings and operational efficiencies, ultimately benefiting patients and healthcare providers. With the merger, Globus seeks to leverage its expanded portfolio and capabilities for future growth. The transaction also led to an expansion of Globus Medical's board of directors to accommodate new board members from NuVasive.
Read more →GMEDGlobus Medical Reports Second Quarter 2023 Results
Globus Medical, Inc. announced its second quarter 2023 financial results, reporting a record net sales of $291.6 million, marking a 10.6% increase compared to the same quarter in 2022. The company achieved a GAAP net income of $57.7 million and disclosed significant growth in its U.S. and international markets. Notably, it launched two innovative products targeting scoliosis, enhancing its portfolio in pediatric care. The company also upgraded its annual guidance for net sales, reflecting strong operational performance.
Read more →GMEDxFEFF;  Globus Medical Reports Second Quarter 2023 Results  AUDUBON, PA
Globus Medical, Inc. reported impressive financial results for Q2 2023, achieving a record revenue of $292 million, up 10.6% from the previous year. The company launched three new products, including two aimed at scoliosis treatment, showcasing its commitment to innovation. U.S. net sales grew by 9%, and international sales increased by over 20%. Globus also raised its full year net sales guidance, signaling strong operational performance and a positive outlook for the remainder of the year, while maintaining a debt-free status.
Read more →GMEDGlobus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
Globus Medical, Inc. has announced the launch of the MARVEL™ Growing Rod System, specifically designed for pediatric patients with early onset scoliosis. This system allows for lengthening through a minimally invasive procedure, minimizing tissue disruption while providing reliable correction. The innovative approach is aimed at balancing spinal growth and curve correction, addressing a significant need in pediatric orthopedic surgery.
Read more →GMEDGlobus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis
AUDUBON, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the REFLECT™ Scoliosis Correction System has been granted approval from the US Food and Drug Administration, as the company’s first human
Read more →GMEDxFEFF;  Globus Medical Reports First Quarter 2023 Results  AUDUBON, PA
Globus Medical, Inc. reported record financial results for the first quarter of 2023, with total revenues reaching $277 million, marking a 21% increase year-over-year. The company also noted a substantial rise in non-GAAP EPS to $0.53, an increase driven by operational efficiencies. The U.S. Spine sector saw a notable growth of 14%, while international sales rose significantly. Additionally, the company reaffirmed its 2023 full-year guidance of $1.1 billion in net sales.
Read more →GMEDGlobus Medical Reports First Quarter 2023 Results
AUDUBON, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2023. Worldwide net sales were $276.7 million, an increase of 20.0%, or 21.0% on a
Read more →GMEDGlobus Medical Shareholders Approve Share Issuance for Merger with NuVasive AUDUBON, Pa.
Globus Medical shareholders have approved the issuance of shares for a merger with NuVasive, enabling each NuVasive share to be exchanged for 0.75 shares of Globus Medical. The strong approval reflects confidence in the merger, which aims to enhance offerings in musculoskeletal solutions. The merger is expected to be completed following regulatory approvals, resulting in NuVasive shareholders owning approximately 28% of the combined entity, while Globus Medical shareholders will retain 72%. Globus Medical is scheduled to release its financial results for Q1 2023 soon after the meeting.
Read more →GMEDxFEFF;  Globus Medical Reports Fourth Quarter and Full Year 20 2 2 Results  AUDUBON, PA, February 21 , 202 3 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announc
Globus Medical, Inc. released its financial results for the fourth quarter and full year of 2022, showcasing impressive growth with net sales surpassing $1 billion. The company reported a 231.4% increase in net income for the fourth quarter year-over-year. Fourth-quarter total sales reached $274.5 million, representing a 9.8% increase from the same period in 2021. Looking forward, Globus Medical anticipates net sales of $1.1 billion and non-GAAP diluted earnings per share of $2.30 for 2023.
Read more →GMEDGlobus Medical Reports Fourth Quarter and Full Year 2022 Results
AUDUBON, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2022. Fourth Quarter 2022: Worldwide net sales were $274.5 mi
Read more →GMED▼ -18.2%on this news
Legal disclaimers No Offer or Solicitation This communication is for informational purposes only and is not intended to and does not constitute an offer to subscribe for, buy or sell, or the solicitation of an offer to s
This communication pertains to a proposed transaction between Globus Medical and NuVasive, detailing legal disclaimers regarding offers to buy or sell securities. It emphasizes the potential risks associated with forward-looking statements concerning the transaction's completion and anticipated benefits. The document highlights uncertainty in achieving shareholder and regulatory approvals, along with unforeseen future liabilities that could adversely affect business operations. Both companies advise investors to consider legal filings and statements related to the proposal carefully.
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
AUDUBON, Pa., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Tuesday, February 21, 2023. A
Read more →GMEDGlobus Medical Partners with the UK’s NHS to Provide Hospitals with Surgical Robotic Navigation Technology
AUDUBON, Pa., Nov. 17, 2022 (GLOBE NEWSWIRE) -- The NHS and Globus Medical have partnered to provide state-of-the-art robotic navigation technology for spinal surgery to NHS hospitals across the United Kingdom. This partnership will allow NHS Trust hospitals to seamlessly impleme
Read more →GMEDGlobus Medical Reports Third Quarter 2022 Results
AUDUBON, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2022. Worldwide net sales were $254.1 million, an increase of 10.6%, or 12.6%
Read more →GMEDxFEFF;  Globus Medical Reports Third Quarter 20 2 2 Results  AUDUBON, PA
Globus Medical Reports Third Quarter 2022 Results AUDUBON, PA, November 8, 2022: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2022. Our third quarter sales grew 12.6% on
Read more →GMEDGlobus Medical Reports Second Quarter 2022 Results
AUDUBON, Pa., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2022. Worldwide net sales were $263.6 million, an increase of 5.0% as reported, an
Read more →GMEDxFEFF;  Globus Medical Reports Second Quarter 20 2 2 Results  AUDUBON, PA, August 4 , 202 2 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial
Globus Medical Reports Second Quarter 2022 Results AUDUBON, PA, August 4, 2022: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2022. Our second quarter record sales grew 6.5% o
Read more →GMEDGlobus Medical Announces First Surgeries Using ExcelsiusGPS In Sydney
WESTMEAD, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today the first spinal surgeries with ExcelsiusGPS® in Sydney were performed at Westmead Private Hospital. ExcelsiusGPS®, the world’s f
Read more →GMEDGlobus Medical Announces First Surgeries Using Excelsius3D™
AUDUBON, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today the first surgeries performed with the Excelsius3D™, an intelligent, intraoperative 3-in-1 imaging platform, the latest addition to Globu
Read more →GMEDGlobus Medical Reports First Quarter 2022 Results
AUDUBON, Pa., May 10, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2022. Worldwide net sales were $230.5 million, an increase of 1.4% as compar
Read more →GMEDxFEFF;  Globus Medical Reports First Quarter 20 2 2 Results  AUDUBON, PA, May 1 0 , 202 2 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial re
Globus Medical Reports First Quarter 2022 Results AUDUBON, PA, May 10, 2022: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2022. Our first quarter results delivered top
Read more →GMEDGlobus Medical Reports CEO Transition and Preliminary First Quarter 2022 Sales Results
AUDUBON, Pa., April 21, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the resignation of President and Chief Executive Officer, Dave Demski, after nearly 20 years with the company, with the last four and
Read more →GMEDxFEFF;  Globus Medical Reports CEO Transition and Preliminary First Quarter 2022 Sales Results  AUDUBON, PA
Globus Medical Reports CEO Transition and Preliminary First Quarter 2022 Sales Results AUDUBON, PA, April 21, 2022: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the resignation of President and Chief Executive Officer, Dave Dems
Read more →GMEDxFEFF;  Globus Medical Announces the Expansion of its Share Repurchase Program  AUDUBON, PA
Globus Medical Announces the Expansion of its Share Repurchase Program AUDUBON, PA, March 4, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has expanded the Company's share repu
Read more →GMEDGlobus Medical Announces the Expansion of its Share Repurchase Program
AUDUBON, Pa., March 04, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has expanded the Company’s share repurchase program by authorizing the repurchase of an additional $200 mil
Read more →GMEDGlobus Medical Reports Fourth Quarter and Full Year 2021 Results
AUDUBON, Pa., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2021. Fourth Quarter 2021: Worldwide net sales were $250.0 mi
Read more →GMEDxFEFF;  Globus Medical Reports Fourth Quarter and Full Year 20 2 1 Results  AUDUBON, PA, February 17 , 202 2 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announc
Globus Medical Reports Fourth Quarter and Full Year 2021 Results AUDUBON, PA, February 17, 2022: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2021. Fourth
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
AUDUBON, Pa., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2021 after the market close on Thursday, February 17, 2022. A
Read more →GMEDxFEFF;  Globus Medical Reports Third Quarter 2021 Results  AUDUBON, PA
Globus Medical Reports Third Quarter 2021 Results AUDUBON, PA, November 4, 2021: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2021. Revenue in the third quarter was $230
Read more →GMEDGlobus Medical Reports Third Quarter 2021 Results
AUDUBON, Pa., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2021. Worldwide net sales were $229.7 million, an increase of 6.3% as compare
Read more →GMEDGlobus Medical Premieres ANTHEM Mini Fragment Fracture System at Orthopaedic Trauma Association Meeting
AUDUBON, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will feature its new ANTHEM® Mini Fragment Fracture System at the annual Orthopaedic Trauma Association (OTA) meeting in Fort Worth, T
Read more →GMEDGlobus Medical Files Suit Against Life Spine for IP Infringement
AUDUBON, Pa., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today filed a lawsuit against Life Spine, Inc. alleging infringement of seven different patents related to Globus Medical’s expandable interbody spacer
Read more →GMEDGlobus Medical to Participate in North American Spine Society Annual Meeting
AUDUBON, Pa., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate in the 36th Annual Meeting of the North American Spine Society (NASS) being held September 29 through October 2, 202
Read more →GMEDGlobus Medical Announces First ExcelsiusGPS Cranial Surgery
AUDUBON, Pa., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the first surgery performed with the ExcelsiusGPS® Cranial Solutions for robot-assisted navigated Deep Brain Stimulation (DBS). Cranial
Read more →GMEDGlobus Medical Announces FDA 510(k) Clearance for Excelsius3D™
AUDUBON, Pa., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that Excelsius3D™, an intelligent intraoperative 3-in-1 imaging system, has been granted 510(k) clearance by the U.S. Food and Drug Admi
Read more →GMEDxFEFF;  Globus Medical Reports Second Quarter 2021 Results  AUDUBON, PA
Globus Medical Reports Second Quarter 2021 Results AUDUBON, PA, August 4, 2021: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2021. Revenue in the second quarter was a record
Read more →GMEDGlobus Medical Reports Second Quarter 2021 Results
AUDUBON, Pa., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2021. Worldwide net sales were $251.0 million, an increase of 68.6% as compared to
Read more →GMEDGlobus Medical Announces Completion of 20,000 Procedures Utilizing ExcelsiusGPS
AUDUBON, Pa., July 15, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that over 20,000 spine procedures have been performed utilizing the ExcelsiusGPS® Robotic Navigation system. “The ExcelsiusGPS® platfor
Read more →GMEDGlobus Medical Reports First Quarter 2021 Results
AUDUBON, Pa., May 04, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2021. Worldwide net sales were $227.3 million, an increase of 19.3% as compared to
Read more →GMEDxFEFF;  Globus Medical Reports First Quarter 2021 Results  AUDUBON, PA, May 4 , 2021 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results
Globus Medical Reports First Quarter 2021 Results AUDUBON, PA, May 4, 2021: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2021. We got off to a great start in the first quart
Read more →GMEDGlobus Medical Announces First Surgeries with Revolutionary CREO ONE™ Robotic Screw
AUDUBON, Pa., April 15, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the recent launch of CREO ONE™, the market’s first robotic screw designed for spine surgery with ExcelsiusGPS®. CREO ONE™ enhances the
Read more →GMEDxFEFF;  Globus Medical Reports Fourth Quarter and Full Year 20 20 Results  AUDUBON, PA, February 17 , 202 1 : Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announce
Globus Medical Reports Fourth Quarter and Full Year 2020 Results AUDUBON, PA, February 17, 2021: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2020. Fourth
Read more →GMEDGlobus Medical Reports Fourth Quarter and Full Year 2020 Results
AUDUBON, Pa., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2020. Fourth Quarter 2020: Worldwide net sales were $233.4 mi
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call
AUDUBON, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2020 after the market close on Wednesday, February 17, 2021.
Read more →GMEDGlobus Medical Trauma Division Awarded Purchasing Agreement with Premier Inc.
AUDUBON, Pa., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, was recently awarded a group purchasing agreement with Premier, one of the largest group purchasing organizations in the United States. The agreement cov
Read more →GMEDGlobus Medical Announces First Surgeries with ExcelsiusGPS Interbody Solutions
AUDUBON, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that Dr. Sheeraz Qureshi (Hospital for Special Surgery, New York, NY) and Dr. Paul Park (University of Michigan, Ann Arbor, MI) were the
Read more →GMEDxFEFF;  Globus Medical Reports Third Quarter 2020 Results  AUDUBON, PA
Globus Medical Reports Third Quarter 2020 Results AUDUBON, PA, October 28, 2020: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2020. The Globus Team executed extremely we
Read more →GMEDGlobus Medical Reports Third Quarter 2020 Results
AUDUBON, Pa., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2020. Worldwide net sales were $216.1 million, an increase of 10.1% as compar
Read more →GMEDGlobus Medical Schedules Third Quarter 2020 Earnings Release and Conference Call
AUDUBON, Pa., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2020 after the market close on Wednesday, October 28, 2020. A copy of the r
Read more →GMEDGlobus Medical to Participate as Platinum Sponsor at North American Spine Society Annual Meeting
AUDUBON, Pa., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate as a platinum sponsor at the North American Spine Society (NASS) Annual Meeting and Virtual Experience hosted online
Read more →GMEDGlobus Medical Reports Second Quarter 2020 Results
AUDUBON, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2020. Worldwide sales were $148.9 million, a decrease of 23.4% as reported
Read more →GMEDxFEFF;  Globus Medical Reports Second Quarter 2020 Results  AUDUBON, PA
Globus Medical Reports Second Quarter 2020 Results AUDUBON, PA, August 5, 2020: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2020. The Globus Team performed extremely
Read more →GMEDGlobus Medical Schedules Second Quarter 2020 Earnings Release and Conference Call
AUDUBON, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended June 30, 2020 after the market close on Wednesday, August 5, 2020. A copy of the release
Read more →GMEDxFEFF;  Globus Medical Reports First Quarter 2020 Results  AUDUBON, PA
Globus Medical Reports First Quarter 2020 Results AUDUBON, PA, May 7, 2020: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2020. The COVID-19 pandemic presents one of th
Read more →GMEDGlobus Medical Reports First Quarter 2020 Results
AUDUBON, Pa., May 07, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2020. Worldwide sales were $190.6 million, an increase of 4.2% as reported
Read more →GMEDGlobus Medical Schedules First Quarter 2020 Earnings Release and Conference Call
AUDUBON, Pa., April 16, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2020 after the market close on Thursday, May 7, 2020. A copy of the release wi
Read more →GMEDStock Repurchase Globus Medical Announces $200 Million Share Repurchase Program  AUDUBON, PA, March 1 1, 2020 (GLOBE NEWSWIRE) – Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, to
Globus Medical Announces $200 Million Share Repurchase Program AUDUBON, PA, March 11, 2020 (GLOBE NEWSWIRE) Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, today announced the Board of Directors authorized the repurchase of $200 million of the Company's
Read more →GMEDGlobus Medical Announces $200 Million Share Repurchase Program
AUDUBON, Pa., March 11, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the Board of Directors authorized the repurchase of $200 million of the Company’s common stock. “We believe the recent stock market vol
Read more →GMEDGlobus Medical Reports Fourth Quarter and Full Year 2019 Results
AUDUBON, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2019. Worldwide sales increased 8.0% as reported to $211.7 mill
Read more →GMEDxFEFF;  Globus Medical Reports Fourth Quarter and Full Year 2019 Results  AUDUBON, PA
Globus Medical Reports Fourth Quarter and Full Year 2019 Results AUDUBON, PA, February 20, 2020: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2019. Globus
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call
AUDUBON, Pa, Feb. 06, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2019 after the market close on Thursday, February 20, 2020. A
Read more →GMEDGlobus Medical Announces First Case with Next Generation 3D Printed Spine Implant
AUDUBON, Pa., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company announced Dr. Joshua S. Rovner became the first spine surgeon to implant HEDRON IA, a 3D printed integrated ALIF spacer that leverages anchors or screws f
Read more →GMEDSales Release   Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results  AUDUBON, PA
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results AUDUBON, PA, January 8, 2020: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full y
Read more →GMEDGlobus Medical Announces Board of Director Addition and Departure
AUDUBON, Pa., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the appointment of Robert Douglas to the Company’s Board of Directors, and the departure of Board member Kurt Wheeler, effective December
Read more →GMEDDirector Change Globus Medical Announces Board of Director Addition and Departure  AUDUBON, PA
Globus Medical Announces Board of Director Addition and Departure AUDUBON, PA, December 13, 2019: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the appointment of Robert Douglas to the Company's Board of Directors, and the departu
Read more →GMEDGlobus Medical Reports Third Quarter 2019 Results
AUDUBON, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2019. Worldwide sales were $196.2 million, an increase of 15.9% as repor
Read more →GMEDxFEFF;  Globus Medical Reports Third Quarter 2019 Results  AUDUBON, PA, November 6 , 2019: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial resu
Globus Medical Reports Third Quarter 2019 Results AUDUBON, PA, November 6, 2019: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2019. Globus Medical had an outstandin
Read more →GMEDGlobus Medical Schedules Third Quarter 2019 Earnings Release and Conference Call
AUDUBON, Pa., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2019 after the market close on Wednesday, November 6, 2019. A copy of the r
Read more →GMEDGlobus Medical Launches AUTOBAHN Intramedullary Nailing Platform at 2019 OTA Annual Meeting
AUDUBON, Pa., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the launch of the AUTOBAHN® Nailing System. This comprehensive platform provides advanced clinical solutions for fractures of the tibia
Read more →GMEDGlobus Medical Showcases Latest Innovations at NASS 2019
AUDUBON, Pa., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will highlight the company’s latest spinal implant and enabling technology innovations at the North American Spine Society (NASS) Annual Meeting held Se
Read more →GMEDxFEFF;  Globus Medical Reports Second Quarter 2019 Results  AUDUBON, PA, August 1 , 2019: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial resul
Globus Medical Reports Second Quarter 2019 Results AUDUBON, PA, August 1, 2019: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2019. Our strong second quarter results dem
Read more →GMEDGlobus Medical Reports Second Quarter 2019 Results
AUDUBON, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2019. Worldwide sales were $194.5 million, an increase of 12.2% as reported
Read more →GMEDGlobus Medical Schedules Second Quarter 2019 Earnings Release and Conference Call
AUDUBON, Pa., July 15, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2019 after the market close on Thursday, August 1, 2019. A copy of the release
Read more →GMEDGlobus Medical Appoints Keith Pfeil as Senior Vice President and CFO
Globus Medical Appoints Keith Pfeil as Senior Vice President and CFO AUDUBON, PA: June 27, 2019: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the appointment of Keith W. Pfeil as its Senior Vice President and Chief Financial Off
Read more →GMEDGlobus Medical Launches First Expandable Interspinous Fixation – AERIAL™
AUDUBON, Pa., May 30, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the launch of AERIAL™, a minimally invasive expandable interspinous fixation system with independent locking plates. The expandable centr
Read more →GMEDGlobus Medical Reports First Quarter 2019 Results
AUDUBON, Pa., May 02, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2019. Worldwide sales were $182.9 million, an increase of 4.9% as reported F
Read more →GMEDGlobus Medical Reports First Quarter 2019 Results AUDUBON, PA
Globus Medical Reports First Quarter 2019 Results AUDUBON, PA, May 2, 2019: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2019. "Our first quarter results demonstrate co
Read more →GMEDGlobus Medical Schedules First Quarter 2019 Earnings Release and Conference Call
AUDUBON, Pa., April 17, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2019 after the market close on Thursday, May 2, 2019. A copy of the release wi
Read more →GMEDGlobus Medical Launches FORTIFY Variable Angle Expandable Corpectomy Spacer System
AUDUBON, Pa., April 15, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the launch of FORTIFY VA™, a variable angle corpectomy solution, to add to its large and growing Expandable Technology portfolio. Globu
Read more →GMEDGlobus Medical Reports Full Year and Fourth Quarter 2018 Results AUDUBON, PA
Globus Medical Reports Full Year and Fourth Quarter 2018 Results AUDUBON, PA, February 21, 2019: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2018. "Our fo
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call
AUDUBON, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2018 after the market close on Thursday, February 21, 2019. A
Read more →GMEDGlobus Medical’s SECURE C Cervical Artificial Disc Receives Expanded Insurance Coverage
AUDUBON, Pa., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, recently announced that the SECURE-C® Cervical Artificial Disc is now covered by Anthem, one of the largest health benefits companies in the United State
Read more →GMEDGlobus Medical Enters International Market with ExcelsiusGPS Robotic Guidance and Navigation System
AUDUBON, Pa., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, recently announced the entrance of ExcelsiusGPS®, a revolutionary robotic guidance and navigation system, to the international market with system install
Read more →GMEDGlobus Medical Reports Third Quarter 2018 Results AUDUBON, PA
Globus Medical Reports Third Quarter 2018 Results AUDUBON, PA, November 8, 2018: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2018. "The third quarter marks the fou
Read more →GMEDGlobus Medical Reports Third Quarter 2018 Results
AUDUBON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2018. Worldwide sales were $169.2 million, an increase of 11.5% as repor
Read more →GMEDGlobus Medical Schedules Third Quarter 2018 Earnings Release and Conference Call
AUDUBON, Pa., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2018 after the market close on Thursday, November 8th, 2018. A copy of the
Read more →GMEDGlobus Medical Supporting Resident and Surgeon Education Workshops at OTA 2018
AUDUBON, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today participation in Educational Workshops at the Orthopedic Trauma Association Annual Meeting October 17th- 20th in Orlando Florida. Durin
Read more →GMEDGlobus Medical Sponsors NASS 2018, Hosts In-Booth Presentations on ExcelsiusGPS
AUDUBON, Pa., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will feature its ExcelsiusGPS® revolutionary robotic guidance and navigation system along with its latest advancements in expandable interbody technolog
Read more →GMEDGlobus Medical Acquires Surgimap
AUDUBON, Pa., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the acquisition of Nemaris Inc., a privately held company that markets and develops Surgimap®, a leading surgical planning software plat
Read more →GMEDGlobus Medical to Exhibit Latest Advancements in MIS Spine Surgery at SMISS Annual Forum
AUDUBON, Pa., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will feature its ExcelsiusGPS® revolutionary robotic guidance and navigation system along with its latest advancements in expandable interbody technology
Read more →GMEDGlobus Medical Reports Second Quarter 2018 Results AUDUBON, PA
Globus Medical Reports Second Quarter 2018 Results AUDUBON, PA, August 1, 2018: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2018. "The second quarter marks the third c
Read more →GMEDGlobus Medical Schedules Second Quarter 2018 Earnings Release and Conference Call
AUDUBON, Pa., July 16, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2018 after the market close on Wednesday, August 1, 2018. A copy of the release
Read more →GMEDGlobus Medical Features Latest Innovative Technologies at Scoliosis Research Society’s International Meeting on Advanced Spine Technologies
AUDUBON, Pa., July 11, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will showcase its advanced technologies at the Scoliosis Research Society’s (SRS) 25th Annual International Meeting on Advanced Spine Techniques (IMAST)
Read more →GMEDGlobus Medical Adds Two Innovative Solutions to Growing Trauma Portfolio
AUDUBON, Pa., July 03, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today the expansion of its orthopedic trauma product portfolio with two new product offerings, the ANTHEM® Ankle Fracture System and the ANTHEM
Read more →GMEDGlobus Medical Announces ExcelsiusGPS Milestone: 3,000 screws implanted
AUDUBON, Pa., June 26, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today a new clinical milestone with the successful implantation of over 3,000 screws using ExcelsiusGPS®, the company’s revolutionary robotic
Read more →GMEDGlobus Medical Launches Cement Augmented Pedicle Screw System
AUDUBON, Pa., June 13, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the launch of the CREO® Fenestrated Screw System used in the treatment of patients with advanced stage tumors of the thoracolumbar spine.
Read more →GMEDGlobus Medical Announces Appointment of Orthopedic Trauma Division’s Vice President of Sales
AUDUBON, Pa., May 21, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the appointment of Daniel Gregoris to Vice President of Sales for the company’s emerging Orthopedic Trauma division. Gregoris will be res
Read more →GMEDGlobus Medical Announces Positive Clinical Results for Lateral Expandable Technology
AUDUBON, Pa., May 15, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the results of the study “Clinical and radiographic analysis of expandable versus static lateral lumbar interbody fusion devices with two-
Read more →GMEDGlobus Medical Announces Corporate Alliance Partnership with the Society of Lateral Access Surgery
AUDUBON, Pa., May 10, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today it is sponsoring the Society of Lateral Access Surgery’s (SOLAS®) newly developed Partnership Program as that organization’s first corpora
Read more →GMEDGlobus Medical Reports First Quarter 2018 Results
AUDUBON, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2018. Worldwide sales were $174.4 million, an increase of 11.9% as reported,
Read more →GMEDGlobus Medical Schedules First Quarter 2018 Earnings Release and Conference Call
AUDUBON, Penn., April 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2018 after the market close on Wednesday, May 2, 2018. A copy of the release
Read more →GMEDGlobus Medical Announces Launch of ELSA Expandable Lateral Spacer System
AUDUBON, Pa., April 05, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the launch of two innovative lateral expandable interbody spacers with integrated screw fixation, ELSA® AL and ELSA®-ATP, the latest add
Read more →GMEDGlobus Medical Enters Trauma Market
AUDUBON, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, is pleased to announce its entry into the orthopedic trauma market. Globus Medical has become a market leader in spinal device innovation, offering diff
Read more →GMEDGlobus Medical Reports Full Year and Fourth Quarter 2017 Results AUDUBON, PA
Globus Medical Reports Full Year and Fourth Quarter 2017 Results AUDUBON, PA, February 21, 2018: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2017. "Fourth
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call
AUDUBON, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2017 after the market close on Wednesday, February 21, 2018.
Read more →GMEDGlobus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results AUDUBON, PA
Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results AUDUBON, PA, January 9, 2018: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year end
Read more →GMEDGlobus Medical Announces Clinical Results Showing Superiority of its SECURE-C to ACDF at Seven Years
AUDUBON, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the results of its seven-year clinical trial follow-up that demonstrate superiority of the SECURE-C® Cervical Artificial Disc over the cu
Read more →GMEDGlobus Medical to Participate in the Piper Jaffray 29th Annual Healthcare Conference
AUDUBON, Pa., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that management plans to participate in the Piper Jaffray 29th Annual Healthcare Conference at the Lotte New York Palace in New York City
Read more →GMEDGlobus Medical Reports Third Quarter 2017 Results AUDUBON, PA
Globus Medical Reports Third Quarter 2017 Results AUDUBON, PA, November 8, 2017: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2017. "We are very pleased with our th
Read more →GMEDGlobus Medical Reports Third Quarter 2017 Results
AUDUBON, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2017. Worldwide sales were $151.7 million, an increase of 11.9% as repor
Read more →GMEDGlobus Medical Schedules Third Quarter 2017 Earnings Release and Conference Call
AUDUBON, Pa., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2017 after the market close on Wednesday, November 8, 2017. A copy of the r
Read more →GMEDGlobus Medical Announces First Spine Surgeries Using ExcelsiusGPS™
AUDUBON, Pa., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the first spine surgeries using ExcelsiusGPS™, a revolutionary robotic guidance and navigation system. Surgeries using ExcelsiusGPS™ were
Read more →GMEDGlobus Medical Announces First Case in Orthopedic Trauma
AUDUBON, Pa., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it completed its first orthopedic trauma surgical case. Globus Medical’s new ANTHEM™ Distal Radius Fracture System was used by Dr. Asif
Read more →GMEDGlobus Medical Appoints David M. Demski as CEO David C. Paul to continue as Executive Chairman AUDUBON, PA
Globus Medical Appoints David M. Demski as CEO David C. Paul to continue as Executive Chairman AUDUBON, PA, August 29, 2017: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that, the Board of Directors has named David M. Demski as
Read more →GMEDGlobus Medical Appoints David M. Demski as CEO
AUDUBON, Penn., Aug. 29, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that, the Board of Directors has named David M. Demski as the Company’s Chief Executive Officer, effective immediately. Mr. Demski wil
Read more →GMEDGlobus Medical Announces FDA 510(k) Clearance for Excelsius GPS Excelsius GPS Robotic Trajectory Guidance and Navigation for Surgery AUDUBON, PA
Globus Medical Announces FDA 510(k) Clearance for Excelsius GPS Excelsius GPS Robotic Trajectory Guidance and Navigation for Surgery AUDUBON, PA, Aug 17, 2017: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that the Excelsius GPS
Read more →GMEDGlobus Medical Reports Second Quarter 2017 Results AUDUBON, PA
Globus Medical Reports Second Quarter 2017 Results AUDUBON, PA, August 2, 2017: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2017. David Paul, Chairman and CEO said,
Read more →GMEDGlobus Medical Announces Acquisition of Robotics Developer KB Medical
AUDUBON, Pa., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions manufacturer, today announced that the acquisition of KB Medical, SA, a robotic developer based in Lausanne, Switzerland, closed during the second quarter of 2017
Read more →GMEDGlobus Medical Schedules Second Quarter 2017 Earnings Release and Conference Call
AUDUBON, Pa., July 10, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the second quarter ended June 30, 2017 after the market close on Wednesday, August 2, 2017. A copy of the rele
Read more →GMEDGlobus Medical Reports First Quarter 2017 Results AUDUBON, PA
Globus Medical Reports First Quarter 2017 Results AUDUBON, PA, May 3, 2017: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2017. David Paul, Chairman and CEO said, "Ou
Read more →GMEDGlobus Medical Reports First Quarter 2017 Results
AUDUBON, Pa., May 03, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2017. Worldwide sales were $155.8 million, an increase of 11.9% as reporte
Read more →GMEDGlobus Medical Schedules First Quarter 2017 Earnings Release and Conference Call
AUDUBON, Pa., April 17, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the first quarter ended March 31, 2017 after the market close on Wednesday, May 3, 2017. A copy of the releas
Read more →GMEDGlobus Medical Reports Full Year and Fourth Quarter 2016 Results AUDUBON, PA
Globus Medical Reports Full Year and Fourth Quarter 2016 Results AUDUBON, PA, February 27, 2017: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the fourth quarter and year ended December 31, 2016. Davi
Read more →GMEDGlobus Medical to Present at Leerink Partners 6th Annual Global Healthcare Conference 2017
AUDUBON, Pa., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that management will present at the Leerink Partners 6th Annual Global Healthcare Conference at the Lotte New York Palace Hotel in New
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call
AUDUBON, Pa., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the fourth quarter and full year ended December 31, 2016 after the market close on Monday, February 27, 2017.
Read more →GMEDGlobus Medical Announces CE Mark for Excelsius GPS™
AUDUBON, Pa., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that the Excelsius GPS™, a revolutionary system providing robotic trajectory guidance and navigation, is now CE marked. This platform
Read more →GMEDGlobus Medical Reports Third Quarter 2016 Results
AUDUBON, Pa., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2016. Worldwide sales decreased 1.0% as reported to $135.7 million, o
Read more →GMEDGlobus Medical Reports Third Quarter 2016 Results AUDUBON, PA
Globus Medical Reports Third Quarter 2016 Results AUDUBON, PA, November 8, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2016. David Paul, Chairman and CEO
Read more →GMEDGlobus Medical Launches INDEPENDENCE MIS™, a Minimally Invasive ALIF Integrated Plate-Spacer
AUDUBON, Pa., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced the introduction of the INDEPENDENCE MIS™ System, an integrated ALIF plate-spacer system designed to simplify implantation and fixatio
Read more →GMEDGlobus Medical Launches QUARTEX™ OCT Stabilization System
AUDUBON, Pa., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, continues to innovate in the treatment of complex spinal instability and deformity with today’s announcement of the launch of the QUARTEX™ OCT Stabili
Read more →GMEDGlobus Medical Schedules Third Quarter 2016 Earnings Release and Conference Call
AUDUBON, Pa., Oct. 19, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the third quarter ended September 30, 2016, after the market close on Tuesday, November 8, 2016. A copy of the
Read more →GMEDGlobus Medical Completes Acquisition of Alphatec's International Business AUDUBON, PA
Globus Medical Completes Acquisition of Alphatec's International Business AUDUBON, PA, September 1, 2016: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has successfully completed the previously announced acquisition o
Read more →GMEDGlobus Medical Announces the Acquisition of Alphatec's International Business AUDUBON, PA
Globus Medical Announces the Acquisition of Alphatec's International Business AUDUBON, PA, July 26, 2016: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has entered into an agreement to acquire the international operat
Read more →GMEDGlobus Medical Reports Second Quarter 2016 Results AUDUBON, PA
Globus Medical Reports Second Quarter 2016 Results AUDUBON, PA, July 26, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2016. David Paul, Chairman and CEO said,
Read more →GMEDGlobus Medical Schedules Second Quarter 2016 Earnings Release and Conference Call
AUDUBON, Pa., July 15, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the second quarter ended June 30, 2016 after the market close on Tuesday, July 26, 2016. A copy of the release
Read more →GMEDGlobus Medical Appoints Eric Ian Schwartz as Senior Vice President and General Counsel
AUDUBON, Pa., May 10, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced it appointed Eric Ian Schwartz as its Senior Vice President and General Counsel effective April 28, 2016. Mr. Schwartz brings to Globu
Read more →GMEDGlobus Medical Reports First Quarter 2016 Results
AUDUBON, Pa., May 03, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2016. Worldwide sales increased 5.8% as reported to $139.3 million, or 6.2
Read more →GMEDGlobus Medical Reports First Quarter 2016 Results AUDUBON, PA
Globus Medical Reports First Quarter 2016 Results AUDUBON, PA, May 3, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2016. David Paul, Chairman and CEO said, "Fi
Read more →GMEDGlobus Medical Schedules First Quarter 2016 Earnings Release and Conference Call
AUDUBON, Pa., April 14, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the first quarter ended March 31, 2016 after the market close on Tuesday, May 3, 2016. A copy of the release
Read more →GMEDGlobus Medical Reports Full Year and Fourth Quarter 2015 Results Record Sales and Profits AUDUBON, PA
Globus Medical Reports Full Year and Fourth Quarter 2015 Results Record Sales and Profits AUDUBON, PA, February 24, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the fourth quarter and year ende
Read more →GMEDGlobus Medical Schedules Fourth Quarter and Full Year 2015 Earnings Release and Conference Call
AUDUBON, Pa., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the fourth quarter and full year ended December 31, 2015 after the market close on Wednesday, February 24, 201
Read more →GMEDGlobus Medical Announces Litigation Settlement Agreement AUDUBON, PA
Globus Medical Announces Litigation Settlement Agreement AUDUBON, PA, January 19, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced DePuy Synthes Products, Inc., DePuy Synthes Sales, Inc. and Globus Medical, Inc. have settled
Read more →GMEDGlobus Medical Reports Preliminary Fourth Quarter and Full Year Record Sales Results AUDUBON, PA
Globus Medical Reports Preliminary Fourth Quarter and Full Year Record Sales Results AUDUBON, PA, January 6, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced preliminary unaudited sales results for the fourth quarter and fu
Read more →GMEDGlobus Medical to Participate in 34th Annual J.P. Morgan Healthcare Conference
AUDUBON, Pa., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, announced today management will participate in J.P. Morgan’s 34th Annual Healthcare Conference at the Westin St. Francis in San Francisco, California.
Read more →GMEDGlobus Medical to Host Analyst Day Meeting Thursday, November 12th
AUDUBON, Pa., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will hold its Analyst Day meeting this Thursday, November 12, 2015. Globus Management’s audio presentation will be webcast live from 9:00am ET to 10:3
Read more →GMEDGlobus Medical Reports Third Quarter 2015 Results Reports Record Quarterly Sales and Increases Guidance AUDUBON, PA
Globus Medical Reports Third Quarter 2015 Results Reports Record Quarterly Sales and Increases Guidance AUDUBON, PA, November 3, 2015: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter e
Read more →GMEDGlobus Medical Reports Third Quarter 2015 Results
AUDUBON, Pa., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2015. Worldwide sales increased 16.3% to $137.0 million, or 17.6% on
Read more →GMEDGLOBUS MEDICAL, INC. SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Against Globus Medical, Inc. -- GMED
RADNOR, Pa., Oct. 26, 2015 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against Globus Medical, Inc. (NYSE:GMED) (“Globus Medical” or the “Company”) on behalf of purchasers of the Company’s
Read more →GMEDGlobus Medical Announces CREO MIS(TM), a Low Profile Minimally Invasive Posterior Stabilization System
AUDUBON, Pa., Oct. 22, 2015 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, announced the introduction of the CREO MIS™ Pedicle Screw System. CREO MIS™ is a thoracolumbar posterior stabilization system featuring extended modu
Read more →GMEDGlobus Medical Schedules Third Quarter 2015 Earnings Release and Conference Call
AUDUBON, Pa, Oct. 12, 2015 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the third quarter ended September 30, 2015 after the market close on Tuesday, November 3, 2015. A copy of the r
Read more →GMEDGlobus Medical Announces Key Executive Changes Dave Demski named Group President, Emerging Technologies Anthony Williams named President of Globus Medical Brett Murphy named Group President, Commercial Operations Audubon
Globus Medical Announces Key Executive Changes Audubon, PA, September 8, 2015: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced a new leadership structure to enhance organizational alignment and continue the Company's industry lea
Read more →GMEDJames R. Tobin, former CEO of Boston Scientific, Joins Globus Medical Board of Directors Audubon, PA
James R. Tobin, former CEO of Boston Scientific, Joins Globus Medical Board of Directors Audubon, PA, August 31, 2015: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that James R. Tobin has been appointed to the company's Board
Read more →GMEDGlobus Medical Reports Second Quarter 2015 Results Reports Record Quarterly Sales and Increases Guidance AUDUBON, PA
Globus Medical Reports Second Quarter 2015 Results Reports Record Quarterly Sales and Increases Guidance AUDUBON, PA, July 30, 2015: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter en
Read more →GMEDGlobus Medical Reports First Quarter 2015 Results AUDUBON, PA
Globus Medical Reports First Quarter 2015 Results AUDUBON, PA, May 5, 2015: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2015. David Paul, Chairman and CEO said, "We
Read more →GMEDGlobus Medical Appoints Daniel Scavilla as Senior Vice President and CFO Audubon, PA
Globus Medical Appoints Daniel Scavilla as Senior Vice President and CFO Audubon, PA, April 23, 2015: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced it appointed Daniel T. Scavilla as its Senior Vice President and Chief Financia
Read more →GMEDGlobus Medical Reports Full Year and Fourth Quarter 2014 Results Record Sales and Profits AUDUBON, PA
Globus Medical Reports Full Year and Fourth Quarter 2014 Results Record Sales and Profits AUDUBON, PA, February 25, 2015: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the fourth quarter and year ende
Read more →GMEDGlobus Medical Reports 2014 Third Quarter Results Record Sales and Profits AUDUBON, PA
Globus Medical Reports 2014 Third Quarter Results Record Sales and Profits AUDUBON, PA, October 30, 2014: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2014. Dav
Read more →GMEDGlobus Medical Announces Acquisition of Transplant Technologies of Texas Audubon, PA
Globus Medical Announces Acquisition of Transplant Technologies of Texas Audubon, PA, October 23, 2014: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of T
Read more →GMEDGlobus Medical Reports 2014 Second Quarter Results AUDUBON, PA
Globus Medical Reports 2014 Second Quarter Results AUDUBON, PA, August 5, 2014: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2014. David Paul, Chairman and CEO said,
Read more →GMEDGlobus Medical Reports 2014 First Quarter Results AUDUBON, PA
Globus Medical Reports 2014 First Quarter Results AUDUBON, PA, April 29, 2014: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2014. "We are pleased with our results th
Read more →GMEDGlobus Medical Reports Full Year and Fourth Quarter 2013 Results AUDUBON, PA
Globus Medical Reports Full Year and Fourth Quarter 2013 Results AUDUBON, PA, February 26, 2014: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the year and fourth quarter ended December 31, 2013. "201
Read more →GMEDGlobus Medical Announces Acquisition of Robotics Developer Excelsius Surgical Audubon, PA
Globus Medical Announces Acquisition of Robotics Developer Excelsius Surgical Audubon, PA, January 8, 2014: Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired Excelsius Surgical. Excelsius Surgical is developin
Read more →GMEDGlobus Medical Reports 2013 Third Quarter Results Record Quarterly Sales AUDUBON, PA
Globus Medical Reports 2013 Third Quarter Results Record Quarterly Sales AUDUBON, PA, October 30, 2013: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the quarter ended September 30, 2013. "We are ver
Read more →GMEDGlobus Medical Reports 2013 Second Quarter Results Record Quarterly Sales AUDUBON, PA
Globus Medical Reports 2013 Second Quarter Results Record Quarterly Sales AUDUBON, PA, August 1, 2013: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the quarter ended June 30, 2013. David Paul, Chair
Read more →GMEDGlobus Medical Announces Jury Verdict in Patent Infringement Lawsuit Audubon, PA
Globus Medical Announces Jury Verdict in Patent Infringement Lawsuit Audubon, PA, June 17, 2013: Globus Medical, Inc. (NYSE: GMED), a leading spinal implant manufacturer, today announced that the jury in a patent infringement case in the U.S. District Court in Delaware brought b
Read more →GMEDGlobus Medical Reports 2013 First Quarter Results AUDUBON, PA
Globus Medical Reports 2013 First Quarter Results AUDUBON, PA, May 2, 2013: Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced its financial results for the quarter ended March 31, 2013. "I am very pleased with this quarter's results, espec
Read more →GMEDGlobus Medical Reports Full Year and Fourth Quarter 2012 Results Record Revenue and Earnings AUDUBON, PA
Globus Medical Reports Full Year and Fourth Quarter 2012 Results Record Revenue and Earnings AUDUBON, PA, February 27, 2013: Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced its financial results for the year and fourth quarter ended Dece
Read more →GMEDGlobus Medical Reports Preliminary Year End Sales Results AUDUBON, PA
Globus Medical Reports Preliminary Year End Sales Results AUDUBON, PA, January 15, 2013: Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced preliminary unaudited sales results for the year ending December 31, 2012, in advance of its national
Read more →GMEDGlobus Medical Reports 2012 Third Quarter Results AUDUBON, PA
Globus Medical Reports 2012 Third Quarter Results AUDUBON, PA, November 1, 2012: Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced its financial results for the quarter ended September 30, 2012. David Paul, Chairman and CEO commented, "Dur
Read more →GMEDGlobus Medical Announces Its First PMA Approval for the SECURE -C Cervical Artificial Disc Audubon, PA
Globus Medical Announces Its First PMA Approval for the SECURE -C Cervical Artificial Disc Audubon, PA, September 28, 2012: Globus Medical, Inc. (NYSE: GMED), today announced that the Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the SECURE -C Cervi
Read more →GMEDGlobus Medical Reports 2012 Second Quarter Results AUDUBON, PA
Globus Medical Reports 2012 Second Quarter Results AUDUBON, PA, August 21, 2012: Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced its financial results for the quarter ended June 30, 2012. David Paul, Chairman and CEO commented, "I am ext
Read more →Competitive Position
How GMED ranks across every disease it competes inCompetitive Position is a premium feature
See how GMED ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial